CN Energy Group. Inc. ("CNEY" or the "Company"), a Nasdaq-listed company, today announced that its wholly-owned subsidiary, Pathenbot Group Inc. ("Pathenbot"), has received the "Best Investment-Ready ...
Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback